Invention Application
US20100178247A1 CA-IX SPECIFIC RADIOPHARMACEUTICALS FOR THE TREATMENT AND IMAGING OF CANCER
失效
CA-IX特异性放射治疗癌症治疗和成像
- Patent Title: CA-IX SPECIFIC RADIOPHARMACEUTICALS FOR THE TREATMENT AND IMAGING OF CANCER
- Patent Title (中): CA-IX特异性放射治疗癌症治疗和成像
-
Application No.: US12631343Application Date: 2009-12-04
-
Publication No.: US20100178247A1Publication Date: 2010-07-15
- Inventor: John W. Babich , Craig Zimmerman , John Joyal , Kevin P. Maresca , Genliang Lu , Shawn Hillier
- Applicant: John W. Babich , Craig Zimmerman , John Joyal , Kevin P. Maresca , Genliang Lu , Shawn Hillier
- Assignee: Molecular Insight Pharmaceuticals, Inc.
- Current Assignee: Molecular Insight Pharmaceuticals, Inc.
- Main IPC: A61K51/04
- IPC: A61K51/04 ; C07D401/12 ; C07F13/00 ; A61K31/444 ; A61K31/555 ; A61K49/00 ; A61P35/00
Abstract:
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula I, II, III, or IV.
Public/Granted literature
- US08211402B2 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer Public/Granted day:2012-07-03
Information query
